Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2016Current Pharmaceutical Design

Therapeutic Antibodies by Phage Display

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHyunbo Shim

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hyunbo Shim (2016) studied this question.

synapsesocial.com/papers/6a91b2f6a51972d869eeeebfhttps://doi.org/10.2174/1381612822666160923113714
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease2007 · 7 citations
  2. 2A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus2011 · 1,693 citations
  3. 3Tailoring in Vitro Selection for a Picomolar Affinity Human Antibody Directed against Vascular Endothelial Growth Factor Receptor 2 for Enhanced Neutralizing Activity2003 · 185 citations